Patrick J. Toomey bought Meddo Company: Meddo (Gurugram, India) Description: Healthcare technology company that connects patients with healthcare providers and clinics in India. (--)
Patrick J. Toomey (R-PA), a U.S. Senator, has disclosed 40 trades in Meddo Company: Meddo (Gurugram, India) Description: Healthcare technology company that connects patients with healthcare providers and clinics in India. (--) since 2012, 16 purchases and 24 sales, worth an estimated $2.5M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Patrick J. Toomey bought $1,001 - $15,000 of Meddo Company: Meddo (Gurugram, India) Description: Healthcare technology company that connects patients with healthcare providers and clinics in India. (--) on February 24, 2022. Since that trade, -- is up +0.00% against the S&P 500 up +86.05%, an outperformance of -86.05%.
Across these filings, Patrick J. Toomey has been a net seller of -- (a buy-to-sell ratio of 0.67). Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Patrick J. Toomey's -- trades vs the price
-- is up +0.00% since Patrick J. Toomey bought on February 24, 2022, versus +86.05% for the S&P 500.
Performance since this trade
All Patrick J. Toomey -- trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Patrick J. Toomey & -- trading FAQ
Is it legal for Patrick J. Toomey to trade Meddo Company: Meddo (Gurugram, India) Description: Healthcare technology company that connects patients with healthcare providers and clinics in India. (--) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Meddo Company: Meddo (Gurugram, India) Description: Healthcare technology company that connects patients with healthcare providers and clinics in India. (--), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.
When did Patrick J. Toomey buy --?
Patrick J. Toomey disclosed a purchase of $1,001 - $15,000 of Meddo Company: Meddo (Gurugram, India) Description: Healthcare technology company that connects patients with healthcare providers and clinics in India. (--) on February 24, 2022, according to public STOCK Act filings.
How has -- performed since Patrick J. Toomey's trade?
Since Patrick J. Toomey bought -- on February 24, 2022, the stock is up +0.00%, versus +86.05% for the S&P 500 over the same period, an outperformance of -86.05%.
How many times has Patrick J. Toomey traded --?
Patrick J. Toomey has disclosed 40 -- trades since 2012 (16 purchases and 24 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional -- trades?
BullishWhales tracks every disclosed congressional trade in Meddo Company: Meddo (Gurugram, India) Description: Healthcare technology company that connects patients with healthcare providers and clinics in India. (--) on the Meddo Company: Meddo (Gurugram, India) Description: Healthcare technology company that connects patients with healthcare providers and clinics in India. congressional trading page, which aggregates filings across all members of Congress.
Patrick J. Toomey's -- tradesAll congressional filings for Meddo Company: Meddo (Gurugram, India) Description: Healthcare technology company that connects patients with healthcare providers and clinics in India.Patrick J. Toomey's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.